From the Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York City, NY (J.J.H., L.G., X.Z., J.B., J.M., C.P.K.).
University of St Thomas, School of Law, Saint Paul, MN (L.A.L.).
Stroke. 2019 Oct;50(10):2858-2864. doi: 10.1161/STROKEAHA.119.025352. Epub 2019 Aug 19.
Background and Purpose- The emergency management of stroke is complex and highly time-sensitive. Recent landmark trials demonstrating the strong benefit of thrombectomy have led to rapid change in stroke management. This article reviews a large number of medical malpractice lawsuits related to the emergency management of stroke to characterize factors involved in these lawsuits. Methods- Three large legal databases were used to search for jury verdicts and settlements in cases related to the acute care of stroke patients in the United States. Search terms included "stroke" and "medical malpractice." Cases were screened to include only cases in which the allegation involved negligence in the acute care of a patient suffering a stroke. Results- We found 246 medical malpractice cases related to the acute management of ischemic stroke and 26 related to intracranial hemorrhage. Seventy-one cases specifically alleged a failure to treat with tPA (tissue-type plasminogen activator) and 7 cases alleged a failure to treat, or to timely treat, with thrombectomy. Overall there were 151 cases (56%) which ended with no payout, 74 cases (27%) were settled out of court, and 47 cases (17%) went to court and resulted in a verdict for the plaintiff. The average payout in settlements was $1 802 693, and the average payout in plaintiff verdicts was $9 705 099. Conclusions- Malpractice litigation is a risk in acute stroke care and can lead to significant financial consequences. The majority of malpractice lawsuits related to the emergency management of stroke allege a failure to diagnose and failure to treat. Allegations of a failure to treat acute ischemic stroke with tPA were frequently found and are common in lawsuits. Allegations of a failure to treat a large vessel occlusion with thrombectomy were less frequently found. Given recent changes in practice guidelines and the demonstrated strong treatment effect of thrombectomy, it is likely that such litigation will increase in the coming years.
背景与目的- 脑卒中的急救管理非常复杂,且对时间高度敏感。近期具有里程碑意义的试验表明取栓治疗具有显著获益,这使得脑卒中的急救管理发生了迅速改变。本文综述了大量与脑卒中急救管理相关的医疗事故诉讼,以明确这些诉讼中涉及的相关因素。
方法- 我们使用三个大型法律数据库在美国检索与急性脑卒中患者救治相关的陪审团裁决和和解案例。检索词包括“stroke”和“medical malpractice”。筛选案例时,仅纳入涉及急性脑卒中患者救治中存在疏忽的过失诉讼案例。
结果- 我们共发现 246 例与急性缺血性脑卒中管理相关、26 例与颅内出血相关的医疗事故诉讼案例。71 例案例明确指控未使用组织型纤溶酶原激活剂(tissue-type plasminogen activator,tPA)治疗,7 例指控未进行取栓治疗或未及时进行取栓治疗。总体而言,151 例(56%)案例未进行任何赔偿,74 例(27%)案例庭外和解,47 例(17%)案例进入庭审并判原告胜诉。和解的平均赔偿金为 1802693 美元,原告胜诉的平均赔偿金为 9705099 美元。
结论- 医疗事故诉讼是急性脑卒中救治中的风险因素,可导致严重的经济后果。与脑卒中急救管理相关的医疗事故诉讼大部分指控为漏诊和未治疗。指控未使用 tPA 治疗急性缺血性脑卒中的情况较为常见,且常出现在诉讼中。指控未使用取栓治疗大血管闭塞的情况则较少见。鉴于近期实践指南的改变以及取栓治疗的显著疗效,此类诉讼在未来几年可能会增加。